Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Total Current Liabilities (2016 - 2025)

LivaNova's Total Current Liabilities history spans 11 years, with the latest figure at $808.1 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 106.08% year-over-year to $808.1 million; the TTM value through Dec 2025 reached $808.1 million, up 106.08%, while the annual FY2025 figure was $808.1 million, 106.08% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $808.1 million at LivaNova, up from $741.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $808.1 million in Q4 2025 and bottomed at $263.9 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $326.1 million (2024), against an average of $440.2 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 161.68% in 2021 before it plummeted 62.42% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $697.0 million in 2021, then plummeted by 57.33% to $297.4 million in 2022, then rose by 12.64% to $335.0 million in 2023, then increased by 17.06% to $392.1 million in 2024, then skyrocketed by 106.08% to $808.1 million in 2025.
  • Per Business Quant, the three most recent readings for LIVN's Total Current Liabilities are $808.1 million (Q4 2025), $741.6 million (Q1 2025), and $392.1 million (Q4 2024).